DB
Daniel Bradbury (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Castle Biosciences, Inc. (CSTL). The largest single filing was $145K of CSTL (4,669 sh × $30.95, as filed), executed Dec 3 2024. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$286K
shares × price, as filed
Last traded
Feb 5 2025
Filed Feb 7 2025
Median ADV $11.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $286K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
CSTLRecent filings
CSTLSALE
Castle Biosciences, Inc.
View filing →
$141K5,017 sh × $28.17
Exec Feb 5 2025
Filed Feb 7 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $145K
4,669 sh × $30.95
Exec Dec 3 2024
Filed Dec 5 2024 · 5:30 PM ET